Stefano Lo Priore, born on 23 June 1968, holds a degree in Industrial Chemistry from the University of Milan and an MBA from the University of Texas at Dallas. His career has focused on microelectronics and biotechnology, first in the production and research and development departments of STMicroelectronics in Italy, then taking responsibility for STM's biomedical activities in the United States, identifying and acquiring the main operators in the sector in the United States and Europe as commercial and technological partners. After further experience in the distribution and marketing of DNA analysis products in Europe, he founded Hyris in 2014 and was then appointed Chairman of Ulisse Biomed following the reverse takeover in December 2023.

Nicola Basile was born on 4 February 1979. He graduated in Economics and Business from La Sapienza University in Rome and obtained an MBA from the MIB School of Business in Trieste. He is an expert in administration, finance, control and revenue management, with over 20 years of experience in multinational companies mainly operating in the FMCG sector, where he has held various positions.

Bruna Marini, born on 29 April 1985. She obtained a PhD in molecular biology from the Scuola Normale Superiore in Pisa for her research carried out at the Molecular Medicine Laboratory at the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Trieste. Her doctoral thesis, focusing on the influence of nuclear architecture on HIV virus integration, was published in Nature. After participating in the "Complex Actions" master's programme, organised by MIB – Trieste School of Management – together with the International School for Advanced Studies (SISSA), she formed a scientific team that gave rise to Ulisse BioMed. Bruna firmly believes that scientific discoveries must be translated into improvements in people's health and well-being. At Ulisse BioMed, she is the main focus of the general organisation and regulatory affairs; she has written and won Italian and European grants worth a total of €1.5 million.

Carlo Montenovesi was born on 1 June 1953. He graduated with honours in Economics from Bocconi University in Milan and subsequently obtained an MBA from INSEAD. He served as General Manager of Ciba Vision and then embarked on a career in M&A, initially with Sopaf, an Italian investment bank listed on the stock exchange, and then as global coordinator of the Healthcare and Pharmaceuticals team in the Global M&A network for about 20 years. He also served as Head of New Business Development at Ciba Geigy, Health Division. In 1990, as a founding partner of Cross Border, an independent financial boutique specialising in M&A and Corporate Finance, Carlo further consolidated his experience in the Healthcare and Life Sciences sector, building on his previous industrial experience. Over the course of a career spanning more than 30 years, he has successfully completed over 400 M&A transactions with industrial counterparties, private equity funds and family businesses, both nationally and internationally. Since 2017, Carlo has served as a member of the board of directors of Hyris Ltd, demonstrating his ongoing commitment to promoting excellence in the industry.

Aurora Agostini, born on 28 January 1982, is a solicitor with extensive experience in technology and privacy law. She is currently a partner at Lexia, where she leads the Data & Technology Innovation team, advising on IT, IP and new technology issues, with a particular focus on personal data protection and GDPR compliance. Over the years, she has served as a board member in various companies, demonstrating strong expertise in corporate governance and contract law. Throughout her career, she has gained extensive experience in legal management for e-commerce platforms, online applications and cloud services, providing ongoing support on compliance issues, contract negotiation and dispute management.